|
Volume 16, Issue 8, August 2009, in PDF
|
   |
Article: 614
Working at the Global Level in China
China’s increasing participation in global drug development programs requires personnel who are experienced working at the global level. Finding such talent is a universal problem, and the problem is exacerbated in emerging markets with shorter clinical research histories.
Article: 615
Stimulus Law Expands HIPAA Requirements
The economic stimulus law passed in February includes changes in HIPAA that become effective in 2010 and represent an expansion of HIPAA requirements for research institutions.
Article: 616
Europe Seeks Boost in Elderly Trial Participants
About one-fifth of Europe’s population is already older than 65 years of age, or classified as “elderly,” and geriatricians and other stakeholders are now asking that more relevant data be available to doctors who prescribe drugs to them. The elderly’s underrepresentation in clinical trials is the main contributor to the lack of relevant data.
Article: 617
Eye On: Lung Cancer
Primary lung cancer arises from tissues within the lung, typically in the cells lining the airways. Small-cell and non-small-cell lung cancer (NSCLC), which are differentiated by their microscopic appearance, are the two leading types of lung cancer.
Price: $59.00
|